Log In
Friday 28th October 2016

Patients denied arthritis drug

19th January 2010

An arthritis drug has been approved for people in Scotland, although the National Institute for Health and Clinical Excellence said it was too expensive for patients in England and Wales.

The drug, Toclizumab, can significantly reduce symptoms. Leading rheumatologist Professor John Isaacs, from the Institute of Cellular Medicine at the University of Newcastle, said: "This is fantastic news for people in Scotland who suffer from this disabling, life-long disease. However, it also highlights the disparities in accessing treatment between Scotland and the rest of the UK."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2016